Union Budget Proposal 2015-16 of India : Is Pharma Industry Now Out of Focus?

Budget Expectations: Overall expectations of the Pharma Industry in India from the Union Budget perspective was very modest this year. The key areas were as follows: – To encourage  innovation, in-house R&D exemption limit was expected to be raised from … Continue reading

Scandalizing Biosimilar Drugs With Safety Concerns

With the patent expiry of exorbitantly priced biologic medicines, introduction of biosimilar drugs are expected to improve their access to millions of patients across the world, saving billions of dollars in healthcare costs in the subsequent years. According to an … Continue reading

Health being a basic human right, the proposal for ‘Universal Health Coverage’ augurs well for India

“The right to health is relevant to all States: every State has ratified at least one international human rights treaty recognizing the right to health. Moreover, States have committed themselves to protecting this right through international declarations, domestic legislation and … Continue reading

Dissapointing: No proposal of ‘Healthcare Reform’ in the Union Budget of India for 2011-12: China rolled it out in 2009.

January 15, 2011 issue of ‘The Lancet’ in an article titled, “Learning from others” states the following: “Having universal coverage through a public commitment does have costs, including public costs. The proportion of national expenditure on health that is met … Continue reading